Effects of Various Hypolipidemic Drugs on Fatty Acid Composition of Liver and Serum Lipids

  • Rene Maier
  • Klaus Muller
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 63)


Despite the extended clinical application hypolipidemic drugs have experienced in the last years, very little hard facts have become known on their mechanism of action. At present drugs belonging to only a few chemical structures are or were in use, namely,
  • the arloxy fatty acids;

  • the derivatives of nicotinic acid;

  • the thyronines;

  • cholesterol and bile acid sequestrants;

  • and, most recently, compounds with antioxidant properties.


Linoleic Acid Fatty Acid Composition Palmitic Acid Nicotinic Acid Lipid Class 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. Jurand and M. F. Oliver. J. Atheroscler. Res. 3: 547, 1963.Google Scholar
  2. 2.
    C. Berry, A. Moxham, E. Smith, A. E. Kellie and J. D. N. Nabarro. J. Atheroscler. Res. 3: 380, 1963.PubMedCrossRefGoogle Scholar
  3. 3.
    M. Hagopian and R. W. Robinson. J. Atheroscler. Res. 8: 21, 1968.PubMedCrossRefGoogle Scholar
  4. 4.
    J. Folch, H. Lees and G. H. Sloane Stanley. J. Biol. Chem. 226: 497, 1957.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • Rene Maier
    • 1
  • Klaus Muller
    • 1
  1. 1.Research Department, Pharmaceuticals DivisionCIBA-GEIGY Ltd.BaselSwitzerland

Personalised recommendations